A team of neuroscientists has identified a group of cells in the hippocampus that can control fear memories. Understanding the mechanisms by which these cells activate and suppress memories could improve therapies for fear-based disorders.
Researchers have demonstrated a number of links between sleep disruption and brain disorders such as concussion, anxiety and dementia; these results could lead to potential circadian rhythm-related treatments in the future.
In this interview, Matthew Hill speaks to us about how endocannabinoids could be a mechanism of comorbidity between inflammatory disease and anxiety.
A preliminary study has revealed that athletes with ADHD may be at greater risk for experiencing persistent anxiety and depression after a concussion.
Scientists have demonstrated how variations in a gene linked to anxiety and depression could affect a patient’s response to treatment.
Researchers reveal that post-traumatic stress disorder, anxiety and some types of inflammation may be alleviated by cannabis-like drugs.
In these interviews, we speak to four early career researchers whose respective research findings were highlighted by the Society as ones to watch in the coming years.
Depression, anxiety, and stress severities in multiple sclerosis patients using injectable vs. oral treatments
This study measures severities of depression, anxiety and stress, and compares them to the used disease-modifying treatment.
The authors assess the value of utilizing pharmacogenetic information to improve antidepressant drug therapy in BPD patients.
Researchers identify a distinct group of hypothalamic neurons implicated in anxiety that could be targeted in future treatments.